ReWalk Robotics, Maker of FDA Approved Exoskeleton, Prepares for $50 Million IPO
Israeli company ReWalk Robotics, which recently received approval from the FDA for its exoskeleton that enables paraplegics to walk, has announced its plan for a $50 IPO, with 3.4 million shares at a price range…
